Tuesday, March 04, 2025 | 08:19 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Markets come off day's high; Nifty hovers around 8,550

ONGC was the top Sensex loser on worries over royalty payments

Image via Shutterstock

<a href="http://www.shutterstock.com/pic-80453707.html" target="_blank">Image</a> via Shutterstock

SI Reporter Mumbai
Benchmark share indices came off their intra-day highs weighed down by oil exploration major ONGC on reports of higher royalty payments.

At 1:50pm, the S&P BSE Sensex was up 35 points at 27,871 and the Nifty 50 index was up 5 points at 8,546.

State-owned oil exploration major ONGC was the top Sensex loser down 2.3% that the company along with Oil India will have to share huge additional expenditure on account of royalty payments from February 2014. Oil India eased 2.5%.

Hindustan Unilever was down 1% ahead of its April-June 2016 quarter earnings later today.

Mortgage lender HDFC erased early gains and was down 1.3% on profit taking.
 
Bharti Airtel was down over 2.2%. The telecom major on Sunday announced increased benefits on select pre-paid data recharge packs and Sachet Packs by offering 25-67% more data at the same price.

Among other shares,
______________________________
(Updated at 12:15pm
After trading in a narrow range in morning trade, key benchmark indices firmed up in mid-morning trade.

At 12:15 PM, the barometer index, the S&P BSE Sensex, was up 156.48 points or 0.56% at 27,992.98. The Nifty 50 index was up 34.85 points or 0.41% at 8,576.25. The Sensex flirted with the psychologically important 28,000 mark.

The Sensex rose 177 points, or 0.64% at the day's high of 28,013.50 in morning trade. The index rose 81.98 points, or 0.29% at the day's low of 27,918.48 in morning trade. The Nifty rose 43.95 points, or 0.51% at the day's high of 8,585.35 in morning trade. The index rose 17.05 points, or 0.20% at the day's low of 8558.45 in morning trade.

The market breadth, indicating the overall health of the market, was strong. On BSE, 1,534 shares rose and 772 shares fell. A total of 115 shares were unchanged. The BSE Mid-Cap index was currently up 0.35%, underperforming the Sensex. The BSE Small-Cap index was currently up 0.72%, outperforming the Sensex.

In overseas markets, most markets in Asia were trading higher today, 18 July 2016, ahead of a relatively data-light week in the region, while investors had a muted reaction to the risks surrounding a failed military coup in Turkey.

In the US market, the Dow Jones Industrial Average edged higher on Friday, 15 July 2016, to post its fourth straight record close, while the S&P 500 broke its win streak as the rally lost strength ahead of the weekend. The Nasdaq Composite Index shed 4.47 points to 5,029.59 but finished the week 1.5% higher.

Most FMCG shares edged higher. Dabur India (up 1.25%), Bajaj Corp (up 0.82%), Colgate Palmolive (India) (up 0.72%), Godrej Consumer Products (up 0.50%), Britannia Industries (up 0.39%), Marico (up 0.32%), GlaxoSmithKline Consumer Healthcare (up 0.28%), Jyothy Laboratories (up 0.10%) and Procter & Gamble Hygiene & Health Care (up 0.07%), edged higher. Nestle India (down 0.07%) and Tata Global Beverages (down 0.34%), edged lower.

FMCG major Hindustan Unilever was down 0.48% ahead of the company's Q1 results today, 18 July 2016.

Pharma stocks were mixed. Aurobindo Pharma (down 0.79%), Cipla (down 0.60%), Wockhardt (down 0.27%), Cadila Healthcare (down 0.14%), Alkem Laboratories (down 0.12%) and GlaxoSmithKline Pharmaceuticals (down 0.05%), edged lower. Piramal Enterprises (up 0.17%), Lupin (up 0.94%), Strides Shasun (up 0.94%), Sun Pharmaceutical Industries (up 1.03%), Divi's Laboratories (up 1.05%) and IPCA Laboratories (up %), edged higher.

Dr Reddy's Laboratories was down 0.11%. The company announced during trading hours today, 18 July 2016, that it has launched Omeprazole and Sodium bicarbonate capsules, 20mg/1100mg and 40mg/1100mg a therapeutic equivalent generic version of Zegerid (omeprazole bicarbonate) capsules in the United States market, having been approved by the US Food & Drug Administration (USFDA).

Glenmark Pharmaceuticals was down 1.34%. The company announced before market hours today, 18 July 2016. that subsequent to the rating received by the leading credit agencies in the world i.e. S&P and Fitch, the company has decided to tap into the International Bond market and is planning to raise around $200 million by issuing dollar denominated non-convertible unsecured bonds. The net proceeds will be used for repaying the existing debt.

IDFC Bank rose 2.72% after the Reserve Bank of India (RBI) allowed foreign investors to enhance investment in the company from the existing 24% to 46%. RBI on Friday, 15 July 2016 notified that foreign institutional investors (FIIs)/registered foreign portfolios investors (RFPIs) can now enhance investment from existing 24% to 46% of the paid up capital of IDFC Bank under the portfolio investment scheme (PIS).

Powered by Capital Market

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 18 2016 | 1:50 PM IST

Explore News